Desmoid tumor medical therapy: Difference between revisions

Jump to navigation Jump to search
 
Line 28: Line 28:
{| class="wikitable"
{| class="wikitable"
|+Different drugs used in medical therapy of desmoid tumors
|+Different drugs used in medical therapy of desmoid tumors
!Drug class
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Drug class
!Drug name
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Drug name
|-
|-
|'''Chemotherapeutic agents'''
|style="background:#DCDCDC;" align="center" + |'''Chemotherapeutic agents'''
|
|
* [[Doxorubicin]] ([[Adriamycin]], [[Doxorubicin hydrochloride|Rubex]])
* [[Doxorubicin]] ([[Adriamycin]], [[Doxorubicin hydrochloride|Rubex]])
Line 41: Line 41:
* [[Carboplatin]] ([[Paraplatin]])
* [[Carboplatin]] ([[Paraplatin]])
|-
|-
|'''NSAIDs'''
|style="background:#DCDCDC;" align="center" + |'''NSAIDs'''
|
|
* [[Sulindac]]
* [[Sulindac]]
|-
|-
|'''Anti-hormonal agents'''  
|style="background:#DCDCDC;" align="center" + |'''Anti-hormonal agents'''  
|
|
* [[Tamoxifen]] ([[Soltamox]], [[Nolvadex]])
* [[Tamoxifen]] ([[Soltamox]], [[Nolvadex]])
* [[Prostaglandin]] inhibitors
* [[Prostaglandin]] inhibitors
|-
|-
|'''Tyrosine kinase inhibitors'''
|style="background:#DCDCDC;" align="center" + |'''Tyrosine kinase inhibitors'''
(Novel [[molecular]] targeted therapies)
(Novel [[molecular]] targeted therapies)
|
|
Line 59: Line 59:
{|
{|
|
|
[[File:Desmoid nsaid regression.png|thumb|400px|none|Desmoid tumour before (A, C) and 2 years after (B, D) the commencement of NSAID. Multi planner reformation (MPR)-CT demonstrates the sporadic desmoid tumours originating from the intra-abdominal cavity (arrows). Frontal (A, B) and axial (C, D) images are shown. The tumour has shown a remarkable shrinkage with a regression rate of 68.5% along with disappearance of intratumoural septa.[https://openi.nlm.nih.gov/detailedresult?img=PMC2270274_1477-7819-6-17-1&query=desmoid%20tumor&it=xg&req=4&npos=13 Source: Tanaka K. et al, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan]]]
[[File:Desmoid nsaid regression.png|thumb|600px|none|Desmoid tumour before (A, C) and 2 years after (B, D) the commencement of NSAID. Multi planner reformation (MPR)-CT demonstrates the sporadic desmoid tumours originating from the intra-abdominal cavity (arrows). Frontal (A, B) and axial (C, D) images are shown. The tumour has shown a remarkable shrinkage with a regression rate of 68.5% along with disappearance of intratumoural septa.[https://openi.nlm.nih.gov/detailedresult?img=PMC2270274_1477-7819-6-17-1&query=desmoid%20tumor&it=xg&req=4&npos=13 Source: Tanaka K. et al, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan]]]
|}
|}



Latest revision as of 03:38, 25 March 2019

Desmoid tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Desmoid tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Wait and watch strategy is applied to desmoid tumors which are asymptomatic, unresectable, non-life threatening, not causing any significant impairment, and resectable tumors with increased morbidity associated with surgery.Different drugs including chemotherapeutic agents, NSAIDs, anti-hormonal agents and tyrosine kinase inhibitors can be used to shrink or stabilize the tumor size and to improve the symptoms. Radiation therapy and tumor ablation with heat, cold, microwave and/or high-frequency ultrasound waves can also be of therapeutic use as required.

Medical Therapy

Different drugs used in medical therapy of desmoid tumors
Drug class Drug name
Chemotherapeutic agents
NSAIDs
Anti-hormonal agents
Tyrosine kinase inhibitors

(Novel molecular targeted therapies)

Desmoid tumour before (A, C) and 2 years after (B, D) the commencement of NSAID. Multi planner reformation (MPR)-CT demonstrates the sporadic desmoid tumours originating from the intra-abdominal cavity (arrows). Frontal (A, B) and axial (C, D) images are shown. The tumour has shown a remarkable shrinkage with a regression rate of 68.5% along with disappearance of intratumoural septa.Source: Tanaka K. et al, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

Radiation Therapy

Tumor ablation

Reference

  1. Wilkinson MJ, Fitzgerald JE, Thomas JM, Hayes AJ, Strauss DC (2012). "Surgical resection for non-familial adenomatous polyposis-related intra-abdominal fibromatosis". BJS. 99 (5): 706–13. doi:10.1002/bjs.8703. PMID 22359346.
  2. Rammohan A, Wood JJ (2012). "Desmoid tumour of the breast as a manifestation of Gardner's syndrome". Int J Surg Case Rep. 3 (5): 139–42. doi:10.1016/j.ijscr.2012.01.004. PMC 3312056. PMID 22370045.

Template:WikiDoc Sources